FDA Inspection
Guangxi Yulin Pharmaceutical Group Co. Ltd.Guangxi Yulin Pharmaceutical Group Co. Ltd. – FDA Inspection, Mar 21, 2025
Record Details
This FDA Inspection record concerns Guangxi Yulin Pharmaceutical Group Co. Ltd., with an inspection on March 21, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- March 21, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 82a89afe-506e-4e84-9dd2-02a225853a04
Inspection Facts
- Inspection number
- 1268116
- FDA center
- Human Drugs
Other FDA inspections of Guangxi Yulin Pharmaceutical Group Co. Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2016 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| September 22, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Guangxi Yulin Pharmaceutical Group Co. Ltd.
- FDA Inspection 992915 - 2016-09-29
- FDA Inspection 748465 - 2011-09-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.